Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-22-000196
Filing Date
2022-01-27
Accepted
2022-01-27 16:34:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 deeptrack-abos012422.htm SC 13G 101413
  Complete submission text file 0001172661-22-000196.txt   102873
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92677 | Film No.: 22563653
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

EIN.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G